DOI QR코드

DOI QR Code

Enoxaparin as an Anticoagulant in a Multipara with a Mechanical Mitral Valve: A Case Report

  • Yo Seb Lee (Department of Thoracic and Cardiovascular Surgery, Konkuk University Medical Center, Konkuk University School of Medicine) ;
  • Jun Seok Kim (Department of Thoracic and Cardiovascular Surgery, Konkuk University Medical Center, Konkuk University School of Medicine)
  • Received : 2023.03.07
  • Accepted : 2023.06.08
  • Published : 2023.11.05

Abstract

Patients who have undergone mechanical valve replacement require anticoagulation therapy with warfarin to prevent thromboembolism. However, administering warfarin to pregnant patients increases their risk of warfarin embryopathy or central nervous system disorders. Consequently, safer alternatives, such as heparin or low-molecular-weight heparin injection, are substituted for warfarin. However, limited research has been conducted on this subject, with no large-scale studies and particularly few investigations involving multiparous patients. A patient who had previously undergone mechanical mitral valve replacement for atrial septal defect and mitral stenosis received anticoagulant therapy with enoxaparin during 2 pregnancies. Upon confirmation of pregnancy, warfarin was replaced with subcutaneously injected enoxaparin with a dosage of 1 mg/kg at 12-hour intervals. The enoxaparin dosage was controlled using an anti-factor Xa assay, with a target range of 0.3-0.7 IU/mL. Intravenous heparin injections were administered starting 3 days prior to the expected delivery date and were continued until delivery, after which warfarin was resumed. No complications were observed during the deliveries.

Keywords

References

  1. Bian C, Qi X, Li L, Zhao J, Liu X. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period. Arch Gynecol Obstet 2016;293:69-74. https://doi.org/10.1007/s00404-015-3768-0
  2. Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tveit A. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:262-7. https://doi.org/10.1016/j.thromres.2008.12.005
  3. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694-8. https://doi.org/10.1001/archinte.163.6.694
  4. Brenner B. Enoxaparin use in pregnancy: state of the art. Womens Health (Lond) 2007;3:9-14. https://doi.org/10.2217/17455057.3.1.9
  5. Daughety MM, Zilberman-Rudenko J, Shatzel JJ, McCarty OJT, Raghunathan V, DeLoughery TG. Management of anticoagulation in pregnant women with mechanical heart valves. Obstet Gynecol Surv 2020;75:190-8. https://doi.org/10.1097/OGX.0000000000000751
  6. Choi SH, Ko KP, Han JO, Chui JB, Kim GH. Anticoagulant therapy in pregnant women with mechanical cardiac valve prostheses. Korean J Thorac Cardiovasc Surg 2000;33:502-6.
  7. Cho H, Kang J, Kim HS, Park KW. Ethnic differences in oral antithrombotic therapy. Korean Circ J 2020;50:645-57. https://doi.org/10.4070/kcj.2020.0098
  8. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89:527-30. https://doi.org/10.1136/heart.89.5.527
  9. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-241. https://doi.org/10.1093/eurheartj/ehy340
  10. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2021;143:e72-227. https://doi.org/10.1161/CIR.0000000000000923
  11. Iscan HZ, Hanedan MO, Ozen A, et al. Anticoagulation therapy in pregnant women with mechanical heart valve. Turk Gogus Kalp Damar Cerrahisi Derg 2018;26:38-44. https://doi.org/10.5606/tgkdc.dergisi.2018.15016
  12. Leyh RG, Fischer S, Ruhparwar A, Haverich A. Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002;21:577-9. https://doi.org/10.1016/s1010-7940(01)01154-x